coil compaction and recanalization and coverage across the neck of the aneurysm was not recognized 1, 3, 7 . In our previous study, coils coated by HAp might enhance intra-aneurysmal scar formation and re-endothelialization across the neck of aneurysm 10 .
Platinum coils were inert and not cell-adhesive. Hydroxyapatite is a biological carrier with enhancement of thrombus organization, and basic FGF is a potent mitogenic agent for wide variety of mesoderm -drived cells including fibroblast, capillary and endocardial endotherial cells, smooth muscle cells. Apatite formation on/in hydrogel matrices were developed using a novel alternate soaking process 12 . This study was designed to check the hypothesis that embolization with coating coils developes endotherialization across the neck in an experimental intracerebral aneurysm model of swine.
Material and Methods

1) Coil Coating
GDC, sizes 18 (6-20 cm length, 3-8 mm helix diameter, platinum coil with 0.015 inches thickness; Boston Scientific Corp., Fremont, CA) was used for embolization. Hydroxyapatite coating method was reported previously. The GDC-HAp were immersed in a solution con-
Summary
The purpose of this study was to evaluate the effect of hydroxyapatite (HAp) and fibroblast growth factor-basic (bFGF) coating on Guglielmi detachable coils (GDCs) in an experimental aneurysm model. A total of 18 aneurysms were experimentally made in the common carotid arteries of swine. Embolization was done on these aneurysms using standard GDCs and coated GDCs with HAp (GDC-HAp) and with bFGF (GDC-HAp-bFGF). The animals were then killed 14 days after embolization. The development of tissue scarring and coverage the aneurysm's orifice were evaluated macroscopically. No significant difference of volume ratio of the coils exited in each groups. Macroscopically, covering ratio of fibrous membrane at the neck of aneurysms were 88.3 ± 14.7% in a group with GDC-HAp-bFGF, while it were 26.7 ± 15.3% in a group with standard GDC and it was 41.7 ± 31.7% in a group with GDC-HAp. These results indicated that coating by hydroxyapatite and bFGF might facilitate a wound healing in an experimental aneurysm model.
Introduction
Several studies dealing with long-term angiographic and histopathologic examinations showed that the treated aneurysms developed taining 1µg/ml recombinant human bFGF (Sigma Corp, St. Louis, USA) during 20 minutes before embolization.
Hydroxyapatite and bFGF Coating of Detachable Coils for Endovascular Occlusion of Experimental Aneurysm
2) Aneurysm Construction and Coil Embolization
The details of aneurysm construction and coil embolizationhave been reported 10 . A total of 18 saccular aneurysms with 5 mm in neck and 6 to 8 mm in length were experimentally made in bilateral common carotid arteries of nine swine using a microsurgical technique. GDCs, were placed in the lumen of the aneurysm until noadditional coils could fit into the aneurysm.
3) Final Angiographic and Histopathologic Studies
Final angiography was performed before killing animals to document the radioanatomical results. Then the aneurysm-parent artery complex was removed and parent artery of the specimens were cut from the bottom to the orifice and direct view of aneurysm orifice and coil surface was obtained and photographically documented.
Results
1) Angiographical Studies
Embolization was performed for 18 aneurysms.
Fourteen days after embolization, three aneurysms had parent artery occlusion and thrombus formation from orifice to parent artery. Angiographic examination in 15 aneurysms were done. Two of three aneurysms embolized by standard GDCs and five of six aneurysms used by GDC-HAp and all GDC-HAp-bFGF demonstrated neally total occlusion (figures 2,3). One standard GDC and one GDC-HAp of these aneurysms showed recanalization. Total length of coils used in each aneurysm were from 28 cm to 72 cm (mean, 51.2 ± 6.2 cm), volume ratio of coils with respect to aneurysmal volume were approximately 18.5% to 25%. Significant difference of volume ratio of the coils in each groups was not recognized (figure 1). Volume ratio of coils; Length of coils x (coil radius) 2 x π /sac volume
2) Macroscopic Findings
Macroscopic examinations of the aneurysms showed significant differences between the standard GDC and GDC-HAp-bFGFs. The surface of the standard GDCs was covered with a thin fibrin-like white material. On the other hand, a denser and thicker fibrous tissue was observed at the neck of aneurysms embolized with GDC-HAp-bFGFs (figures 2,3) . The predominantly fibrous scarring was covered with neoendothelium arising from the edges of the neck of the aneurysm. Covering of fibrous membrane in the orifice was 26.7% of the aneurysms embolized by standard GDCs, 41.7 ± 31.7% of those by GDC-HAps, 88.3 ± 14.7% of those by GDC-HAp-bFGF ( figure 4 ). There was statistically significant difference (P < 0.05) between standard GDCs and GDC-HAp-bFGF.
Discussion
We found that embolization with GDC coated by HAp and bFGF stimulate the healing process of lateral wall aneurysm of swine model. Fibrous menbrane covering of neck were recognized in GDC coated by HAp and bFGF, compared with of standard GDCs.
Several studies have stated that important anatomic limitations on complete occlusion associated with this endovascular therapeutic procedure 1, 6, 13 . Platinum is inert biologically and does not elicit a significant biological response on its surface. Coating on platinum with proteins might be difficult, by polyester fiber 5 collagen cores 2 , incorporating collagen thread 11 , ion implantation with fibronectin, laminin 8 to modify coil thrombogenicity and inflammatory cellular response.
In this study, we used GDCs coated by HAp whitch enhance thrombogenecity and bFGF whitch promote neointimal hyperplasia in the healing process of aneurysm.
There are several limitations in our study. Lateral side wall aneurysm in the swine has a strong tendency for spontaneous wound healing. Owing to apprehension of the exess thrombogenecity of HAp, we performed strict heparinization and anti-platelet drugs similar to clinical procedure 10 . Three of 18 aneurysms em-bolized had parent artery occlusion. Thrombogenecity play an important role in the first stage of wound healing and then ECM and basicc Fibroblast growth factor (bFGF) play same role in second stage 9, 14 .
Some studies have examined the effect of various proteins on SMC proliferation, attachment, and the growth of endothelial cells derived from artery wall 13 . In second limitation, We used infiltration of GDC-HAp into a solution containing 1µg/ml bFGF. But, activity of bFGF is very short. We reported histologic changes in aneurysms embolized with GDCs-HAp in the early stage 10 . Coating of surfice GDC-HAp using other proteins such as bonding with bFGF, may be of value in late stage of complete aneurismal occlusion.
Conclusions
GDCs coated by HAp and bFGF show a faster neoendothelial proliferation in the aneurysm neck.
Such promoted biological response may decrease the chances of coil compaction and recanalization in human cerebral aneurysms treated by GDCs.
